Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases.
Total raised: $75M
Investors 2
| Date | Name | Website |
| - | Catalio Ca... | cataliocap... |
| 09.02.2024 | Hawktail M... | hawktail.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.08.2023 | Series A | $75M | BioVenture... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 03.04.2024 | From generative chemistry to computational astrophysics, sta... | Here are a few startups in the cancer space that made headlines recently The recent revelation of Pr... | vator.tv/n... |
| 18.08.2023 | Georgiamune: Clinical-Stage Biotechnology Company Closes $75... | Georgiamune – a privately held clinical-stage biotechnology company – recently announced the clearan... | pulse2.com... |
| 16.08.2023 | DC Money Moves: ASRC Federal subsidiary secures an $8B contr... | Money Moves is a column where we chart the funding raises of tech companies across the region. Have ... | technical.... |
| 09.08.2023 | Georgiamune Closes $75M Series A Financing | Georgiamune Inc., a Gaithersburg, Md.-based clinical stage biotechnology company working in the fiel... | finsmes.co... |
| - | Georgiamune | “Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases... | fastfounde... |